Solara Active Pharma Sciences Limited (NSE:SOLARA)

Market Cap	25.67B
Revenue (ttm)	13.10B
Net Income (ttm)	-2.53B
Shares Out	48.05M
EPS (ttm)	-97.95
PE Ratio	n/a
Forward PE	21.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	126,098
Average Volume	88,696
Open	518.50
Previous Close	518.50
Day's Range	518.50 - 548.90
52-Week Range	366.70 - 882.80
Beta	1.25
RSI	56.20
Earnings Date	Apr 29, 2025

About NSE:SOLARA

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antif...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 2,156
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SOLARA

Financial Performance

In 2023, NSE:SOLARA's revenue was 12.89 billion, a decrease of -10.73% compared to the previous year's 14.44 billion. Losses were -5.67 billion, 2458.1% more than in 2022.